DNA methylation polymerase chain reaction (PCR) array of apoptosis-related genes in pleomorphic adenomas of the salivary glands.

[1]  C. Gomes,et al.  DNA methylation pattern of apoptosis-related genes in ameloblastoma. , 2017, Oral diseases.

[2]  Peter A. Jones,et al.  Targeting the cancer epigenome for therapy , 2016, Nature Reviews Genetics.

[3]  L. Kowalski,et al.  Evaluation of a subset of tumor suppressor gene for copy number and epigenitic changes in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma carcinogenesis. , 2016, Oral surgery, oral medicine, oral pathology and oral radiology.

[4]  C. Gomes,et al.  Intratumor molecular heterogeneity in pleomorphic adenoma of the salivary glands. , 2016, Oral surgery, oral medicine, oral pathology and oral radiology.

[5]  M. Bullock,et al.  DNA Methylation Analysis: Choosing the Right Method , 2016, Biology.

[6]  N. Nikolic,et al.  High frequency of p16 and p14 promoter hypermethylation and marked telomere instability in salivary gland tumors. , 2015, Archives of oral biology.

[7]  Yangxing Zhao,et al.  RASSF1A Promoter Hypermethylation Is a Strong Biomarker of Poor Survival in Patients with Salivary Adenoid Cystic Carcinoma in a Chinese Population , 2014, PloS one.

[8]  D. Kordi-Tamandani,et al.  Analysis of methylation and mRNA expression status ofFADD andFAS genes in patients with oral squamous cell carcinoma , 2014, Medicina oral, patologia oral y cirugia bucal.

[9]  C. Leles,et al.  Pleomorphic adenoma of oral minor salivary glands: An investigation of its neoplastic potential based on apoptosis, mucosecretory activity and cellular proliferation. , 2014, Archives of oral biology.

[10]  A. Reis,et al.  Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence , 2014, Cell Death and Disease.

[11]  Mathieu Blanchette,et al.  The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts , 2014, Genome Biology.

[12]  R. Carroll,et al.  Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation , 2014, Experimental biology and medicine.

[13]  P. Cartron,et al.  DNA Methylation and Apoptosis Resistance in Cancer Cells , 2013, Cells.

[14]  S. Palma.  Carcinoma Ex Pleomorphic Adenoma, with Particular Emphasis on Early Lesions , 2013 .

[15]  S. Horvath,et al.  Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects , 2012, BMC Genomics.

[16]  G. Martinelli,et al.  DNA hypermethylation promotes the low expression of pro‐apoptotic BCL2L11 associated with BCR‐ABL1 fusion gene of chronic myeloid leukaemia , 2012, British journal of haematology.

[17]  Alfonso Valencia,et al.  Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia , 2012, Nature Genetics.

[18]  Annabelle L. Fonseca,et al.  Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors , 2012, Genes, chromosomes & cancer.

[19]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[20]  C. Gomes,et al.  Anti-apoptotic gene transcription signature of salivary gland neoplasms , 2012, BMC Cancer.

[21]  Jiang Li,et al.  Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma. , 2011, Archives of pathology & laboratory medicine.

[22]  Randal S. Weber,et al.  CpG island methylation profiling in human salivary gland adenoid cystic carcinoma , 2011, Cancer.

[23]  Zheng‐gang Liu,et al.  The Adaptor Protein TRADD Is Essential for TNF-Like Ligand 1A/Death Receptor 3 Signaling , 2011, The Journal of Immunology.

[24]  R. Shaw,et al.  Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma , 2010, British Journal of Cancer.

[25]  T. Kuwana,et al.  BH3 Domains other than Bim and Bid Can Directly Activate Bax/Bak* , 2010, The Journal of Biological Chemistry.

[26]  Allen D. Delaney,et al.  Conserved Role of Intragenic DNA Methylation in Regulating Alternative Promoters , 2010, Nature.

[27]  R. Henrique,et al.  Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer , 2010, Apoptosis.

[28]  J. Martinez-Climent,et al.  Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia. , 2009, European journal of cancer.

[29]  Robert E. White,et al.  Epstein-Barr Virus Latency in B Cells Leads to Epigenetic Repression and CpG Methylation of the Tumour Suppressor Gene Bim , 2009, PLoS pathogens.

[30]  C. Gomes,et al.  Immunolocalization of DNMT1 and DNMT3a in salivary gland neoplasms. , 2009 .

[31]  Mihaela Campan,et al.  Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer , 2008, Molecular Cancer.

[32]  M. Calaza,et al.  Reference genes for normalization of gene expression studies in human osteoarthritic articular cartilage , 2008, BMC Molecular Biology.

[33]  Haruhiko Soma,et al.  A direct repeat of E-box-like elements is required for cell-autonomous circadian rhythm of clock genes , 2008, BMC Molecular Biology.

[34]  B. Gillissen,et al.  Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance , 2007, Oncogene.

[35]  P. Nicolai,et al.  Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature , 2007, European Archives of Oto-Rhino-Laryngology.

[36]  Ceri M. Wiggins,et al.  Bim and the Pro-Survival Bcl-2 Proteins: Opposites Attract, ERK Repels , 2007, Cell cycle.

[37]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[38]  M. Esteller.  Epigenetic gene silencing in cancer: the DNA hypermethylome. , 2007, Human molecular genetics.

[39]  S. Cross,et al.  Promoter Hypermethylation Identifies Progression Risk in Bladder Cancer , 2007, Clinical Cancer Research.

[40]  Michael W Pfaffl,et al.  RNA integrity and the effect on the real-time qRT-PCR performance. , 2006, Molecular aspects of medicine.

[41]  U. Bunz.  How Are Alkynes Scrambled? , 2005, Science.

[42]  Gangning Liang,et al.  Detection of Methylated Apoptosis-Associated Genes in Urine Sediments of Bladder Cancer Patients , 2004, Clinical Cancer Research.

[43]  K. Tsukinoki,et al.  Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis. , 2004, Oral oncology.

[44]  C. Mărgăritescu,et al.  The ultrastructural aspects of neoplastic myoepithelial cell in pleomorphic adenomas of salivary glands , 2004, Journal of cellular and molecular medicine.

[45]  Luca Scorrano,et al.  Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. , 2003, Biochemical and biophysical research communications.

[46]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[47]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[48]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[49]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[50]  K. Bauer,et al.  Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB , 1996, Current Biology.

[51]  A. Chinnaiyan,et al.  Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95 , 1996, Science.

[52]  R Holliday,et al.  DNA modification mechanisms and gene activity during development , 1975, Science.

[53]  J. McKENDRICK.  On Modes of Demonstrating the Action of the Membrana Tympani , 1876, Nature.

[54]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[55]  J. Tschopp,et al.  TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). , 1997, Immunity.

[56]  R. Spiro.  Salivary neoplasms: overview of a 35-year experience with 2,807 patients. , 1986, Head & neck surgery.

[57]  Arthur D. Riggs,et al.  X inactivation, differentiation, and DNA methylation. , 1975, Cytogenetics and cell genetics.